REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial (REVERENT)

Clinical Trial ID NCT02499822

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02499822

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).	J Hypertens	2013	18.17
2	Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.	Lancet	2010	8.39
3	Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.	Lancet	2010	4.06
4	Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.	Hypertension	2012	2.53
5	Assessment and management of blood-pressure variability.	Nat Rev Cardiol	2013	1.84
6	Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats.	J Hypertens	2003	1.49
7	Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment.	J Hypertens	2012	1.09
8	Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.	J Am Soc Hypertens	2014	0.88
9	Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.	Hypertens Res	2014	0.77
10	Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes.	J Diabetes Investig	2013	0.75